2023 - 01 - 20
Medspray Pharma BV has secured the second round of funding from the Bill & Melinda Gates Foundation to develop a non-invasive liquid surfactant nebulizer for premature babies. We aim to […]
2021 - 12 - 13
Successful trial phase for treatment of COVID-19 induced hypoxemia Phase IIb clinical trial executed with Medspray nozzle technology for treatment of COVID-19 induced hypoxemia. Our daughter company Resyca has supplied […]
2021 - 06 - 02
Medspray Pharma BV has secured funding from the Bill & Melinda Gates Foundation to develop a new way of delivering medication to babies. We aim to develop a new, non-invasive […]
2021 - 02 - 02
Medspray has joined forces with contract development and manufacturing organization Recipharm in the joint venture Resyca BV. Together, they will develop and exploit a unique soft mist spray nozzle technology […]
2020 - 12 - 18
After two years of joint development Radboud umc gets the first batch of Trachosprays. These CE marked medical devices have an optimized droplet size that covers exactly the right areas […]
2020 - 05 - 27
Medspray is developing a spraying adapter, that can be placed in the breathing circuit of a ventilated patient in the intensive care unit. The syringe can be filled with medication […]
Showing 1 - 2 of 8 results
Design: Brand Specials